Characteristics | Number of cases (Cohort 1) | SATB2-AS1 expression | P valuea | Number of cases (Cohort 2) | SATB2-AS1 expression | P valuea | ||
---|---|---|---|---|---|---|---|---|
Low (n= 63) | High (n= 63) | Low (n= 91) | High (n= 91) | |||||
Age (year) | ||||||||
 ≤ 60 | 61 | 31 | 30 | 0.859 | 96 | 48 | 48 | 0.882 |
 > 60 | 65 | 32 | 33 | 86 | 43 | 43 | ||
Gender | ||||||||
 Female | 54 | 27 | 27 | 1.000 | 88 | 38 | 50 | 0.102 |
 Male | 72 | 36 | 36 | 94 | 53 | 41 | ||
Tumor invasion depth | ||||||||
 T1-2 | 63 | 21 | 42 | < 0.001 | 81 | 32 | 49 | 0.017 |
 T3-4 | 63 | 42 | 21 | 101 | 59 | 42 | ||
Lymph node metastasis | ||||||||
 N0 | 70 | 24 | 46 | < 0.001 | 106 | 39 | 67 | < 0.001 |
 N1+N2 | 56 | 39 | 17 | 76 | 52 | 24 | ||
Distant metastasis | ||||||||
 M0 | 111 | 50 | 61 | 0.002 | 157 | 70 | 87 | < 0.001 |
 M1+M2 | 15 | 13 | 2 | 25 | 21 | 4 | ||
TNM stage | ||||||||
 I+II | 67 | 22 | 45 | < 0.001 | 97 | 33 | 64 | < 0.001 |
 III+III | 59 | 41 | 18 | 85 | 58 | 27 |